Recombinant Vibrio vulnificus Protein hfq (hfq)

Shipped with Ice Packs
In Stock

Description

Definition and Basic Properties

Recombinant V. vulnificus Protein Hfq is produced in Escherichia coli using standard molecular cloning techniques. Key characteristics include:

PropertyDetail
Source OrganismVibrio vulnificus (strain YJ016)
Expression HostE. coli
Purity>85% (verified by SDS-PAGE)
Molecular Weight~9.8 kDa (86 amino acids)
Storage Stability12 months (lyophilized) at -20°C/-80°C; 6 months (liquid form)
ReconstitutionDeionized sterile water with 50% glycerol for long-term storage

The full amino acid sequence is:
MAKGQSLQDP FLNALRRERI PVSIYLVNGI KLQGQIESFD QFVILLKNTV NQMVYKHAIS TVVPARPVSH HSGERGSDRP SEKSED .

Post-Transcriptional Regulation

  • RpoS Stabilization: Hfq enhances the stability and translation of rpoS mRNA, which encodes the stress-response sigma factor σ<sup>S</sup>. Deletion of hfq reduces RpoS protein levels, impairing stress adaptation .

  • sRNA Interactions: While V. vulnificus Hfq binds sRNAs (e.g., RyhB), it does not regulate the iron-responsive fur gene, unlike E. coli Hfq .

Stress Response

  • Oxidative Stress: Hfq indirectly modulates oxidative stress tolerance by regulating RpoS-dependent pathways .

  • Envelope Stress: Influences outer membrane protein composition through interactions with sRNAs, though specific mechanisms in V. vulnificus remain under investigation .

Virulence

  • Toxin Production: While not directly linked to the multifunctional-autoprocessing RTX (MARTX) toxin in V. vulnificus, Hfq may regulate other virulence factors through sRNA partnerships .

Table 1: Experimental Insights from V. vulnificus Hfq Studies

Study FocusOutcomeCitation
hfq deletion phenotypeReduced RpoS levels, unchanged Fur protein levels
RNA chaperone activityBinds sRNAs but does not mediate fur autoregulation
Structural homologyRetains conserved RNA-binding domains despite C-terminal divergence
Recombinant utilityEnables in vitro studies of Hfq-RNA interactions and stress pathways

Applications in Research

  • Mechanistic Studies: Used to elucidate Hfq’s role in quorum sensing, iron regulation, and stress responses .

  • Drug Development: Serves as a target for anti-virulence therapies aimed at disrupting bacterial RNA networks .

Product Specs

Form
Lyophilized powder Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on purchasing method and location. Please consult your local distributor for precise delivery estimates. Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process. The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
hfq; VV3071; RNA-binding protein Hfq
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-86
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
hfq
Target Protein Sequence
MAKGQSLQDP FLNALRRERI PVSIYLVNGI KLQGQIESFD QFVILLKNTV NQMVYKHAIS TVVPARPVSH HSGERGSDRP SEKSED
Uniprot No.

Target Background

Function

Recombinant *Vibrio vulnificus* Protein hfq (hfq): An RNA chaperone that binds small regulatory RNAs (sRNAs) and mRNAs, facilitating mRNA translational regulation in response to envelope stress, environmental stress, and changes in metabolite concentrations. It also exhibits high-affinity binding to tRNAs.

Database Links

KEGG: vvy:VV3071

Protein Families
Hfq family

Q&A

What is the hfq protein in Vibrio vulnificus and what is its primary function?

Hfq in Vibrio vulnificus, similar to its homolog in V. alginolyticus, functions as a global regulatory RNA chaperone that facilitates interactions between small regulatory RNAs (sRNAs) and their mRNA targets. This protein plays a crucial role in post-transcriptional regulation of gene expression, particularly for adaptation to environmental stresses and virulence regulation. Research shows that Hfq mediates RNA-RNA interactions by binding to AU-rich sequences and stabilizing sRNA-mRNA complexes, thereby influencing translation efficiency and mRNA stability . These regulatory functions make Hfq central to bacterial adaptation mechanisms and pathogenicity pathways in Vibrio species.

How does the structure of recombinant V. vulnificus Hfq compare to other Vibrio species?

Recombinant V. vulnificus Hfq likely shares structural similarities with other Vibrio Hfq proteins, forming a homohexameric ring structure with proximal and distal faces that interact with different RNA species. While specific structural data from V. vulnificus Hfq is limited, studies on related Vibrio species suggest conservation of key structural domains. The protein contains an Sm-like fold characteristic of RNA-binding proteins. Comparative analysis with V. alginolyticus Hfq indicates the presence of conserved RNA-binding motifs that facilitate sRNA-mRNA interactions . These structural features enable Hfq to simultaneously bind multiple RNA partners, explaining its efficiency as a global regulator in bacterial gene expression networks.

What phenotypic changes are associated with hfq deletion in Vibrio species?

Deletion of hfq in Vibrio species produces multiple phenotypic alterations that highlight its global regulatory role. In V. alginolyticus, hfq deletion results in:

  • Altered colony morphology (shifting from translucent/smooth to opaque/rugose colonies)

  • Significant reduction in extracellular polysaccharide (EPS) production

  • General growth impairment in both rich media and minimal media with different carbon sources

  • Enhanced sensitivity to oxidative stress and multiple antibiotics

  • Dramatic transcriptomic changes affecting 306 protein-coding genes (179 upregulated, 127 downregulated)

These phenotypic changes likely parallel effects in V. vulnificus, indicating Hfq's central role in stress response, growth regulation, and virulence factor expression across Vibrio species.

How does Hfq coordinate with the ToxRS system in regulating virulence in V. vulnificus?

The relationship between Hfq and the ToxRS system in V. vulnificus represents a complex regulatory network controlling virulence expression. While direct experimental data on this specific interaction is limited, we can infer potential mechanisms based on related research. The ToxRS system in V. vulnificus has been established as a transmembrane transcription activator that regulates virulence genes, including the hemolysin gene (vvhA) . Hfq likely influences this system through post-transcriptional regulation of mRNAs involved in the ToxRS regulatory cascade.

The potential interactions could occur through several mechanisms:

  • Hfq-dependent sRNAs may regulate translation or stability of toxR/toxS transcripts

  • Hfq might modulate expression of downstream targets of ToxRS regulation

  • Both regulatory systems could converge on shared virulence targets like VVH

In V. vulnificus, ToxRS enhances expression of the hemolysin gene (vvhA) approximately fivefold , while transcriptomic analysis of hfq mutants in related Vibrio species shows significant alterations in virulence gene expression . This suggests a potential coordinated regulation where both systems influence overlapping sets of virulence determinants.

What are the methodological challenges in producing functional recombinant V. vulnificus Hfq for structural studies?

Producing functional recombinant V. vulnificus Hfq presents several methodological challenges that researchers must address:

  • Expression system optimization: The hexameric nature of Hfq requires maintaining proper oligomerization during recombinant expression. Expressing in E. coli systems may require optimization of induction parameters (temperature, IPTG concentration) to prevent inclusion body formation while maintaining proper folding.

  • Purification complexity: The RNA-binding nature of Hfq means recombinant preparations are often contaminated with host RNA molecules. Effective purification requires establishing a protocol combining affinity chromatography (His-tag or GST-tag approaches) with additional RNA removal steps, potentially including high-salt washes or RNase treatment followed by size exclusion chromatography.

  • Functional validation challenges: Confirming proper activity of purified recombinant Hfq requires specialized RNA-binding assays. Electrophoretic mobility shift assays (EMSAs) with known sRNA targets or surface plasmon resonance (SPR) techniques must be optimized specifically for Vibrio Hfq-RNA interactions.

  • Stability considerations: Maintaining the hexameric structure during purification and storage requires buffer optimization to prevent dissociation or aggregation, potentially including specific concentrations of stabilizing agents.

These challenges can be addressed through systematic optimization of expression and purification protocols, with careful validation of functional activity at each step.

How do transcriptomic profiles differ between wild-type and hfq-mutant V. vulnificus under various stress conditions?

Transcriptomic profiling of hfq mutants versus wild-type V. vulnificus under various stress conditions would likely reveal distinct expression patterns reflecting Hfq's central role in stress adaptation. While specific V. vulnificus data is limited, research in V. alginolyticus provides valuable insights. In V. alginolyticus, hfq deletion resulted in significant transcriptomic changes affecting 306 protein-coding genes (179 upregulated, 127 downregulated) .

Under different stress conditions, we would expect:

Oxidative stress response:

  • Upregulation of oxidative stress genes in hfq mutants even under basal conditions

  • Dysregulated expression of ROS-detoxifying enzymes (catalase, superoxide dismutase)

  • Impaired coordination of antioxidant responses under hydrogen peroxide challenge

Nutrient limitation:

  • Altered expression of metabolic pathway genes in minimal media conditions

  • Dysregulation of carbon source utilization genes

  • Impaired expression of amino acid biosynthesis and transport systems

Host-mimicking conditions:

  • Disrupted expression of virulence factors (including hemolysin)

  • Altered regulation of iron acquisition systems

  • Dysregulation of genes involved in environmental sensing

These differences would manifest in distinct expression signatures that could be analyzed through RNA-seq, microarray, or qRT-PCR approaches to identify direct and indirect Hfq targets under each stress condition.

What are the optimal conditions for expressing and purifying recombinant V. vulnificus Hfq protein?

Expression optimization:
For optimal expression of recombinant V. vulnificus Hfq, researchers should consider:

  • Expression system: BL21(DE3) E. coli strain with pET-based vectors containing a His6-tag for purification

  • Induction parameters:

    • Temperature: 18-22°C for overnight induction to minimize inclusion body formation

    • IPTG concentration: 0.1-0.5 mM, with lower concentrations favoring soluble expression

    • OD600 at induction: Mid-log phase (0.6-0.8) for optimal yield

  • Growth media: Enhanced yield in Terrific Broth compared to standard LB media

Purification protocol:

  • Cell lysis using sonication in buffer containing 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 5% glycerol, 5 mM β-mercaptoethanol

  • Initial Ni-NTA affinity chromatography with imidazole gradient elution

  • RNase A treatment (10 μg/ml) at 37°C for 30 minutes to remove bound RNAs

  • Second round of affinity chromatography to remove RNase

  • Size exclusion chromatography to ensure hexameric assembly

  • Final buffer exchange to storage buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 1 mM DTT, 10% glycerol)

This approach yields functionally active hexameric Hfq protein with minimal RNA contamination, suitable for downstream structural and functional studies.

What methods are most effective for studying Hfq-sRNA interactions in V. vulnificus?

Multiple complementary approaches provide robust analysis of Hfq-sRNA interactions in V. vulnificus:

In vitro methods:

  • Electrophoretic Mobility Shift Assays (EMSA): Using purified recombinant Hfq and in vitro transcribed sRNAs to determine binding affinities and specificities

  • Surface Plasmon Resonance (SPR): For real-time kinetic analysis of Hfq-RNA interactions

  • Microscale Thermophoresis (MST): For quantitative binding affinity measurements in solution

  • RNA footprinting: Using chemical or enzymatic probes to identify Hfq binding sites on target RNAs

In vivo methods:

  • RNA Immunoprecipitation (RIP): Using anti-Hfq antibodies to identify sRNAs associated with Hfq in vivo

  • CLIP-seq (Cross-linking immunoprecipitation): To map Hfq binding sites across the transcriptome with nucleotide resolution

  • Bacterial three-hybrid assays: To detect and validate specific Hfq-sRNA-mRNA interactions

  • Reporter gene fusions: To monitor effects of Hfq-sRNA regulation on target gene expression

These methodologies provide complementary data on physical interactions, binding specificity, and functional outcomes of Hfq-sRNA partnerships in V. vulnificus regulatory networks.

How can genetic complementation experiments be designed to validate hfq phenotypes in V. vulnificus?

Robust genetic complementation experiments for validating hfq phenotypes in V. vulnificus should follow this methodological framework:

Vector construction:

  • Amplify the wild-type hfq gene with its native promoter (300-500 bp upstream region) using high-fidelity polymerase

  • Clone into a stable, low-copy plasmid vector appropriate for Vibrio species (e.g., pVSV105 or pMMB207)

  • Include appropriate antibiotic resistance marker (different from that used in mutant construction)

  • Verify construct by sequencing to ensure no mutations were introduced

Complementation strategy:

  • Transform the construct into the Δhfq mutant strain via electroporation or conjugation

  • Select transformants on appropriate antibiotics and verify presence of plasmid

  • Create control strains: wild-type with empty vector and Δhfq with empty vector

Phenotypic validation:

  • Assess multiple phenotypes under identical conditions for all strains:

    • Colony morphology on solid media

    • Growth curves in rich and minimal media

    • Extracellular polysaccharide production quantification

    • Stress tolerance assays (oxidative, osmotic, temperature)

    • Virulence factor expression

  • Conduct quantitative real-time PCR to verify restoration of key gene expression patterns

  • Perform complementation with point mutants to identify critical residues for Hfq function

A properly designed complementation experiment should restore wild-type phenotypes in the mutant strain, confirming that observed defects are specifically due to hfq deletion rather than polar effects or secondary mutations.

How should researchers interpret contradictory findings between V. vulnificus Hfq studies and those in other Vibrio species?

When interpreting contradictory findings between V. vulnificus Hfq studies and those in other Vibrio species, researchers should apply a systematic analytical approach:

  • Evaluate methodological differences:

    • Expression systems used (homologous vs. heterologous)

    • Purification protocols and protein tagging strategies

    • Experimental conditions (temperature, pH, salt concentration)

    • Growth phase of bacterial cultures

  • Consider species-specific regulatory networks:

    • Different sRNA repertoires between Vibrio species

    • Species-specific transcription factor interactions

    • Evolutionary divergence in Hfq recognition motifs

    • Niche-specific adaptations influencing regulatory priorities

  • Assess genetic background effects:

    • Different wild-type strains used (clinical vs. environmental isolates)

    • Secondary mutations in laboratory strains

    • Plasmid copy number effects in complementation studies

  • Analyze result reporting standardization:

    • Different metrics for quantifying similar phenotypes

    • Variations in statistical analysis approaches

    • Threshold definitions for significance

When specific contradictions arise, direct comparative experiments using standardized methods across multiple Vibrio species can resolve whether differences reflect true biological variation or methodological artifacts. This might include expressing Hfq proteins from different Vibrio species in a common Δhfq background and assessing complementation efficiency across multiple phenotypes.

What bioinformatic approaches are most suitable for identifying Hfq-regulated sRNAs in V. vulnificus?

Identifying Hfq-regulated sRNAs in V. vulnificus requires a multi-faceted bioinformatic approach:

  • Comparative genomics pipeline:

    • Identify conserved intergenic regions across Vibrio species

    • Search for Rho-independent terminators and promoter elements

    • Analyze sequence conservation patterns indicative of functional RNAs

    • Utilize tools like SIPHT, sRNAPredict, or RNAz

  • RNA-seq based discovery:

    • Differential RNA-seq (dRNA-seq) to map transcription start sites

    • Compare transcriptomes of wild-type and Δhfq strains under various conditions

    • Apply specialized sRNA detection algorithms (e.g., ANNOgesic, DETR'PROK)

    • Normalize and analyze using DESeq2 or edgeR packages

  • Structural motif identification:

    • Search for Hfq binding motifs (AU-rich sequences, U-rich tails)

    • Analyze RNA secondary structure predictions using RNAfold or mfold

    • Identify structurally conserved elements across predicted sRNAs

  • Interaction prediction:

    • Employ CopraRNA, IntaRNA or RNApredator to predict sRNA-mRNA interactions

    • Correlate predicted interactions with expression changes in Δhfq strains

    • Validate top candidates experimentally

  • Integration with experimental data:

    • Incorporate CLIP-seq or RIP-seq data if available

    • Filter candidates based on Hfq-dependency in expression data

    • Prioritize sRNAs with expression correlation to known virulence pathways

This integrated approach generates a prioritized list of candidate Hfq-regulated sRNAs for experimental validation, with higher confidence predictions emerging from candidates identified by multiple methods.

How might recombinant V. vulnificus Hfq be utilized in developing novel antimicrobial strategies?

Recombinant V. vulnificus Hfq offers several innovative platforms for antimicrobial development:

  • High-throughput screening platforms:

    • Utilize purified Hfq in fluorescence-based RNA binding assays to screen for small molecules that disrupt Hfq-sRNA interactions

    • Develop cell-based reporter systems where Hfq-dependent regulation controls expression of fluorescent or luminescent markers

    • These platforms could identify compounds that selectively target Vibrio Hfq function

  • Structural biology approaches:

    • Solve crystal structures of V. vulnificus Hfq alone and in complex with target RNAs

    • Use structure-based virtual screening to identify small molecules that bind to RNA-binding surfaces

    • Rational design of peptidomimetics that compete with sRNAs for Hfq binding sites

  • Anti-virulence applications:

    • Since Hfq regulates virulence without being essential for viability under standard conditions, targeting it may reduce selection pressure for resistance

    • Compounds that inhibit Hfq function could attenuate virulence while allowing host immune clearance

    • This approach may be particularly valuable given the emerging antibiotic resistance in Vibrio species

  • Delivery systems:

    • Develop anti-Hfq compounds conjugated to Vibrio-specific targeting moieties

    • Engineer bacteriophage to deliver anti-sense RNAs targeting hfq expression

    • Create nanoparticle formulations that penetrate Vibrio biofilms to deliver Hfq inhibitors

The main advantage of targeting Hfq lies in its central regulatory role - disrupting it would simultaneously compromise multiple virulence and stress adaptation systems, potentially making it harder for the pathogen to develop resistance through single mutations.

What emerging technologies could advance our understanding of V. vulnificus Hfq regulatory networks?

Several cutting-edge technologies show particular promise for elucidating V. vulnificus Hfq regulatory networks:

  • Single-cell RNA sequencing approaches:

    • Applying bacterial single-cell transcriptomics to capture cell-to-cell variability in Hfq-dependent gene expression

    • Revealing stochastic effects and subpopulation behaviors in Hfq regulatory networks

    • Potential to identify condition-specific activation of distinct regulatory modules

  • Advanced structural biology techniques:

    • Cryo-electron microscopy to resolve structures of Hfq-sRNA-mRNA ternary complexes

    • Hydrogen-deuterium exchange mass spectrometry to map dynamic interactions

    • NMR studies to capture conformational changes during RNA binding events

  • CRISPR-based technologies:

    • CRISPRi for selective downregulation of suspected Hfq target genes

    • CRISPR-Cas13 RNA targeting to disrupt specific sRNA-Hfq interactions

    • Pooled CRISPR screens to identify genes with synthetic phenotypes with hfq mutations

  • RNA-protein interaction mapping:

    • RIP-seq with tailored analysis pipelines for bacterial systems

    • CLIP-seq and related crosslinking methods for transcriptome-wide binding site mapping

    • Proximity-dependent RNA labeling techniques adapted for bacterial systems

  • Systems biology integration:

    • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics

    • Network modeling to predict emergent properties of Hfq regulatory circuits

    • Machine learning applications to identify complex regulatory patterns

These technologies, especially when applied in combination, offer unprecedented potential to resolve the complex regulatory networks centered on Hfq in V. vulnificus, potentially revealing new targets for antimicrobial development.

How might comparative studies between different Vibrio species enhance our understanding of Hfq function in V. vulnificus?

Comparative studies across Vibrio species offer powerful insights into V. vulnificus Hfq function through several approaches:

  • Evolutionary analysis of Hfq and its targets:

    • Phylogenetic analysis of Hfq protein sequences across Vibrio species

    • Identification of conserved versus species-specific Hfq binding motifs

    • Tracking co-evolution of Hfq with its sRNA and mRNA targets

    • These analyses could reveal core versus niche-specific regulatory functions

  • Cross-species complementation experiments:

    • Expressing Hfq proteins from different Vibrio species in V. vulnificus Δhfq background

    • Assessing restoration of various phenotypes (growth, stress resistance, virulence)

    • Identifying species-specific versus universal functions

    • Analysis of domain-swapped chimeric proteins to pinpoint functional regions

  • Comparative transcriptomics:

    • Parallel RNA-seq analysis of Δhfq mutants across multiple Vibrio species

    • Identification of conserved Hfq regulons versus species-specific targets

    • Meta-analysis to strengthen predictions of direct versus indirect regulation

  • Ecological context integration:

    • Correlating Hfq regulatory differences with ecological niches of Vibrio species

    • Connecting regulatory divergence to host specificity or environmental adaptation

    • Identifying selection pressures driving Hfq functional evolution

Such comparative approaches would not only enhance understanding of V. vulnificus Hfq specifically, but would also reveal broader principles of RNA-based regulation in bacterial adaptation and virulence that could inform development of species-specific or broad-spectrum therapeutic approaches targeting Vibrio pathogens.

What are the most significant gaps in our current knowledge about V. vulnificus Hfq?

Despite advances in understanding bacterial RNA chaperones, several critical knowledge gaps remain regarding V. vulnificus Hfq:

Addressing these gaps will require integration of advanced structural biology, transcriptomics, and in vivo imaging approaches specifically targeting V. vulnificus regulatory systems.

How might research on V. vulnificus Hfq translate to improved management of infections?

Research on V. vulnificus Hfq has several translational pathways toward improved clinical management:

  • Diagnostic applications:

    • Development of molecular diagnostic tests targeting Hfq-regulated genes as virulence markers

    • Creation of rapid tests to detect virulent strains based on Hfq-dependent expression profiles

    • Potential use of Hfq-regulated sRNAs as biomarkers for virulence potential or antibiotic resistance

  • Therapeutic targeting:

    • Design of small molecules disrupting Hfq-RNA interactions as novel antimicrobials

    • Development of antisense oligonucleotides targeting critical Hfq-dependent sRNAs

    • Potential for anti-virulence therapies that disarm rather than kill the pathogen, reducing selection for resistance

  • Predictive modeling:

    • Using Hfq regulatory networks to predict environmental conditions favoring V. vulnificus outbreaks

    • Modeling virulence expression under different host conditions to guide preventive measures

    • Forecasting potential evolution of increased virulence in response to environmental changes

  • Vaccine development:

    • Identification of consistently expressed Hfq-regulated surface antigens as vaccine targets

    • Creation of attenuated vaccine strains through targeted modification of Hfq regulatory networks

    • Development of subunit vaccines based on Hfq-regulated virulence factors

  • Combination therapies:

    • Rational design of antibiotic combinations based on understanding of Hfq's role in stress responses

    • Development of adjunct therapies targeting Hfq function to enhance antibiotic efficacy

    • Creating treatment protocols that account for Hfq-dependent adaptation to host environments

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.